Olha Ya. Tkachenko

Olha Ya. Tkachenko

Auto-generated profile, based on publicly available information

Olha Ya. Tkachenko

POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2021 in CHILD`S HEALTH
Verified
Journal Article
Open access
PDF file
TKT.O. Kruchko
T.O. Kruchko
OTO.YA. Tkachenko
O.YA. Tkachenko
VSV.V. Sherbak
V.V. Sherbak
IKI.O. Kolenko
I.O. Kolenko
LBL.M. Bubyr
L.M. Bubyr
Among all allergic diseases in pediatric practice, allergic rhinitis is one of the most common pathologies of the upper respiratory tract. This review deals with the problem of modern principles for the diagnosis and treatment of allergic rhinitis in children based on the analysis of literature sources using electronic databases PubMed, Web of Science, MedLine, the Cochrane Library. Allergic rhinitis is an important medical and social problem of our time the importance of which has increased significantly in recent years. The growing number of people sensitized to pollen, the variety of symptoms and the negative impact on the quality of life of patients make pollen allergy one of the major problems in pediatrics. Despite the development of international national protocols and clinical guidelines, in many countries the control of allergic rhinitis in children remains insufficient. Therefore, it is necessary to take into account the individual characteristics of patients, pay attention to both nasal and extranasal symptoms, consider all pathognomonic diagnostic aspects, because the underdiagnosis of this allergic disease leads to inadequate therapy, complications, more severe atopy and reduced quality of children’s life in general. Recently, there is growing evidence of the need for personalized selection of the most effective therapy for allergic rhinitis in children. In-depth study of the pathogenetic role of circadian molecular clock in children with seasonal allergic rhinitis using informative molecular genetic methods may allow characterizing in detail the mechanism of regulation of allergic inflammation of the upper airway mucosa and evaluating the role of circadian genes in the development of allergic diseases, in particular allergic rhinitis. In the future, these studies may become an alternative to improve control over the course of allergy and the organization of a comprehensive monitoring system, development of new strategies for the treatment and prevention of allergic rhinitis in children.

25 March 2023 in CHILD`S HEALTH
Verified
Journal Article
Open access
PDF file
OAO.E. Abaturov
O.E. Abaturov
TKT.O. Kryuchko
T.O. Kryuchko
OKO.L. Kryvusha
O.L. Kryvusha
VBV.L. Babych
V.L. Babych
NTN.M. Tokareva
N.M. Tokareva
OTO.Y. Tkachenko
O.Y. Tkachenko
Background. A balanced supply of macro- and microelements to various organs and systems is a prerequisite for maintaining human health. Deficiency or excess of macro- and microelements in saliva can be associated with both inflammation and oxidative damage to the oral tissues. Provision of calcium in the human body significantly affects the state of salivary ionome. However, currently there are few studies on the effect of Ca and vitamin D on the state of salivary ionome in healthy children. Purpose: to study the effect of combined use of prophylactic doses of Ca and vitamin D on the concentration of macro- and microelements in saliva of young children. Materials and methods. Under our supervision, there were 36 clinically healthy young children who received Calcicare 2.5 ml 3 times a day for 2 months. The study of the content of macro- and microelements in urine was carried out by optical emission spectrometry with an inductively coupled plasma. Statistical analysis of the results was performed using the application package Statistica 6.1 on a personal computer based on Intel Pentium processor. Results. The study showed that the combined use of calcium carbonate and vitamin D significantly changes the concentration of some macro- and microelements in saliva of young children. The level of some trace elements in saliva before the start of therapy with Calcicare correlated with the frequency of acute respiratory infections. Thus, a higher incidence of acute respiratory infections was observed in children with reduced salivary excretion of Ca and S. Young children had a low concentration of Ca and Mg in saliva before the course of Calcicare therapy. Treatment with Calcicare led to an activation of the metabolism of these macronutrients in saliva of young children, which was characterized by an increase in the level of Ca from 29.5 ± 4.4 mg/l to 60.1 ± 6.8 mg/l (p < 0.01), Mg from 4.9 ± 0.6 mg/l to 9.3 ± 0.8 mg/l (p < 0.01), S from 336.3 ± 3.8 mg/l to 2501.6 ± 275.4 mg/l (p < 0.01), and P from 5.6 ± 0.3 mg/l to 15.8 ± 0.7 mg/l (p < 0.01). An increase in the concentration of Ca and P in saliva after the treatment with Calcicare probably has an anti-caries effect. An increase in the level of Mg in saliva after the course of Calcicare may have anti-inflammatory and antitumor effect on the oral mucosa. Co-administration of calcium carbonate and vitamin D led to the disappearance of salivary excretion of some trace elements such as B, Cd, Li, Pb, which may relieve the oral mucosa and dental tissues from the toxic effects of these trace elements. Conclusions. The combined use of calcium carbonate and vitamin D (Calcicare) for 2 months in young children is accompanied by changes in salivary ionome, which are of anti-inflammatory and anti-caries nature. After taking calcium carbonate and vitamin D, there was a cessation of salivary excretion of some trace elements, which have a toxic effect on the oral tissues. The use of Calcicare in the recommended dose of 2.5 ml 3 times a day for 2 months is characterized by a high safety profile and can be recommended for young children, especially those at risk of developing calcium deficiency.

24 October 2017
Verified
Journal Article
Closed access
TKTetyana O Kryuchko
Tetyana O Kryuchko
INInna Nesina
Inna Nesina
OTOlha Tkachenko
Olha Tkachenko

28 March 2017
Verified
Journal Article
Closed access
VHVira Harshman
Vira Harshman
TKTetyana O Kryuchko
Tetyana O Kryuchko
IKIryna O Kolenko
Iryna O Kolenko
TKTetyana V Kushnereva
Tetyana V Kushnereva
OTOlha Tkachenko
Olha Tkachenko

1 May 2019 in Wiadomości Lekarskie
Verified
Journal Article
Closed access
OPOlha A. Poda
Olha A. Poda
TKTetyana O. Kryuchko
Tetyana O. Kryuchko
INInna N. Nesina
Inna N. Nesina
OTOlha Ya. Tkachenko
Olha Ya. Tkachenko
NKNataliia V. Kuzmenko
Nataliia V. Kuzmenko
Introduction: Nowadays anti-microbial therapy of ventilator-associated pneumonia caused by is one of the most topical issue as a consequence of widespread multiresistant strains of causative agent and their biological peculiarity of actively formation of resistance to new antibacterial drugs. The aim is to describe modern approaches to therapy of ventilator-associated pneumonia causative agent of which is presented by Pseudomonas aureginosa . Materials and methods: An analysis and summing up of results of scientific investigations described in medical publications concerning the issues of therapy of ventilatorassociated pneumonia caused by Pseudomonas aureginosa was done. Conclusions: Despite the development of modern approaches to anti-microbial therapy of ventilator-associated pneumonia caused by Pseudomonas aeruginosa, which are also concerned with such controversial issues as correct choice of antibacterial drug, its optimal dose, and duration of this therapy, the problem of treatment of hospital-acquired infections of respiratory airways caused by Pseudomonas aeruginosa has been discussable yet and requires the further study.

31 August 2023
Verified
Journal Article
Open access
INInna M. Nesina
Inna M. Nesina
TKTetyana O. Kryuchko
Tetyana O. Kryuchko
OPOlha A. Poda
Olha A. Poda
OTOlha Ya. Tkachenko
Olha Ya. Tkachenko
NKNataliia V. Kuzmenko
Nataliia V. Kuzmenko
LBLiudmyla M. Bubyr
Liudmyla M. Bubyr
Peculiarities of the course of chronic viral hepatitis B in children cause an important medical and social problem of health care, despite the implementation of modern treatment and prevention protocols. Pathogenetic mechanisms of the development and progression of viral hepatitis B infection, the presence of occult poorly diagnosed form, the impossibility of completely eliminating the virus and the specificity of the immune response in children are still not fully solved scientific problems. The aim of this review is to examine current strategies for the diagnosis and treatment of chronic hepatitis B in children, based on international and national guidelines. A detailed analysis of modern guidelines on the course and pathogenesis of viral hepatitis B infection confirms the fact that chronic hepatitis B is characterised by a complex interaction between the immune system of the virus and the patient, whose dynamic balance is not only responsible for the various phases of chronic viral hepatitis B infection but also leads to the result of antiviral treatment. Despite the introduction of vaccination of children against hepatitis B, the level of viral hepatitis B vaccination of children in Ukraine remains insufficient, which leads to the further spread of the infection. Currently available antiviral drugs can provide functional treatment of viral hepatitis B infection in a limited number of patients, but today's Ukrainian realities have caused a change in approach to the treatment and monitoring of patients, which may negatively affect the implementation of the key goals of the World Health Organization Global Strategy on the prevention, diagnosis and treatment of viral hepatitis.